Finance

Bioanalytical measurement company reports first quarter 2003 results

Published in Biotech Business Week, May 19th, 2003

Molecular Devices Corp. (MDCC) announced its revenues and earnings for the quarter ended March 31, 2003.

Revenues and earnings per share for the quarter were within management's previously stated guidance and met consensus analyst expectations.

Revenues for the first quarter of 2003 were a record $24.7 million, or an increase of 20% compared to the same period last year. Fully diluted earnings per share were flat compared to the same period last year at $0.05 for the quarter.

"We are pleased that we were able to meet our financial and strategic objectives during the quarter, even in this difficult economic environment," stated...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2003-05-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry